A Hybrid Machine Learning Model Based on Semantic Information Can Optimize Treatment Decision for Naïve Single 3-5-cm
Wenzhen Ding1, Zhen Wang1, Fang-Yi Liu1
1Department of Interventional Ultrasound, The First Center of Chinese PLA General Hospital, Beijing, China.
A new hybrid machine learning model accurately predicts early recurrence risk for hepatocellular carcinoma (HCC) patients, guiding optimal treatment selection between laparoscopic hepatectomy and microwave ablation to reduce recurrence rates.
Area of Science:
- Hepatocellular Carcinoma (HCC) Research
- Machine Learning in Oncology
- Treatment Optimization Strategies
Background:
- Tumor recurrence remains a significant challenge for hepatocellular carcinoma (HCC) patients undergoing local treatment.
- Identifying optimal initial treatment strategies is crucial for improving patient outcomes.
Purpose of the Study:
- To develop a hybrid machine learning model for recommending the optimal first treatment (laparoscopic hepatectomy [LH] or microwave ablation [MWA]) for single 3-5-cm HCC patients.
- To predict the probability of early recurrence (ER; ≤2 years) to guide treatment decisions.
Main Methods:
- Retrospective analysis of 582 HCC patients (LH: 300, MWA: 282) with 20 semantic variables and ≥24 months follow-up.
- Building and comparing five machine learning algorithms (logistic regression, random forest, neural network, stochastic gradient boosting, XGBoost) to create optimized LH and MWA models.
- Developing a hybrid model integrating LH-XGBoost and MWA-stochastic gradient models to predict ER probability and guide treatment decisions.
Main Results:
- The hybrid model achieved high predictive accuracy, with LH-XGBoost (AUC=0.744) and MWA-stochastic gradient (AUC=0.750) models selected.
- Predicted ER probabilities closely matched actual ER rates (p > 0.05).
- Adherence to model recommendations significantly reduced ER rates (LH: 21.2% vs. 46.2%; MWA: 26.3% vs. 54.1%; p < 0.05), decreasing overall ER from 38.2% to 25.6% (p < 0.001).
Conclusions:
- The hybrid machine learning model accurately predicts ER probability for different treatments in single 3-5-cm HCC.
- This model provides reliable evidence for optimizing initial treatment decisions, thereby reducing tumor recurrence.
- The findings support the use of AI-driven tools for personalized HCC treatment planning.
More Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
